^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
BIOMARKER:

MUC13 overexpression

i
Other names: MUC13, Mucin 13, Cell Surface Associated, Down-Regulated In Colon Cancer 1, DRCC1, Mucin 13, Epithelial Transmembrane, Mucin-13, MUC-13, RECC
Entrez ID:
1m
Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance. (PubMed, Cancer Metastasis Rev)
Notably, MUC13 has also been implicated in the development of chemoresistance, rendering cancer cells less responsive to traditional treatment options. Understanding the precise role of MUC13 in cellular plasticity, and chemoresistance could pave the way for the development of targeted therapies to combat cancer progression and enhance treatment efficacy.
Review • Journal
|
MUC13 (Mucin 13)
|
MUC13 overexpression • MUC1 overexpression
2ms
GCNT3 regulated MUC13 to promote the development of hepatocellular carcinoma through the GSK3β/β-catenin pathway. (PubMed, Dig Liver Dis)
GCNT3 regulated tumor progression in HCC through the MUC13/GSK3-β/β-catenin signaling pathway.
Journal
|
MUC13 (Mucin 13)
|
MUC13 overexpression
10ms
MUC13 promotes the development of esophageal cancer by upregulating the expression of O-glycan process-related molecules. (PubMed, Discov Oncol)
This study proved that MUC13 is an important molecule that regulates the O-glycan process and then affects the progress of esophageal cancer. MUC13 may be a novel therapeutic target for patients with esophageal cancer.
Journal
|
MUC4 (Mucin 4, Cell Surface Associated) • MUC13 (Mucin 13) • MUC2 (Mucin 2)
|
MUC13 overexpression • MUC4 expression • MUC1 overexpression
12ms
Low Expression of Mucin 2, High Expression of Mucin 13, and High Expression of Nuclear Factor Kappa-Light-Enhancer of Activated B Cells were Significant Pathways in Colorectal Cancer Development. (PubMed, Asian Pac J Cancer Prev)
There was a significantly lower MUC2, higher MUC13, and higher NFκB expression in the carcinogenesis of colorectal cancer, representing the influence of the inflammatory pathway and the abnormality of the protective barrier. Therefore, in the future, this result could remark a future early prediction or scoring system to assess colorectal cancer in clinical application.
Journal
|
MUC13 (Mucin 13) • MUC2 (Mucin 2)
|
MUC13 overexpression
12ms
Mucin-microbiome signatures shape the tumor microenvironment in gastric cancer. (PubMed, Microbiome)
Our results emphasize key roles for mucins in gastric cancer prognosis and shaping microbial networks in the tumor microenvironment. Specifically, the enriched oral taxa associated with aberrant MUC13 expression can be potential biomarkers in predicting disease outcomes. Video Abstract.
Journal
|
MUC13 (Mucin 13) • MUC5AC (Mucin 5AC) • MUC6 (Mucin 6)
|
MUC13 overexpression • MUC1 overexpression
1year
MUCIN-MICROBIOME SIGNATURES SHAPE THE TUMOUR MICROENVIRONMENT IN GASTRIC CANCER (DDW 2023)
Our results emphasize key roles for mucins in gastric cancer prognosis and shaping microbial networks in the tumour microenvironment. Specifically, the enriched oral taxa associated with aberrant MUC13 expression can be potential biomarkers in predicting disease outcome.
MUC1 (Mucin 1) • MUC4 (Mucin 4, Cell Surface Associated) • MUC13 (Mucin 13) • MUC2 (Mucin 2) • MUC5AC (Mucin 5AC) • MUC6 (Mucin 6)
|
MUC13 overexpression • MUC1 overexpression